Using soluble urokinase plasminogen activator receptor to stratify patients for medication review in the emergency department-Reference-Cited by-同舟云学术

Using soluble urokinase plasminogen activator receptor to stratify patients for medication review in the emergency department

Published:2021-08-02 Issue: Volume: Page:
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Bengaard Anne Kathrine¹²³^ORCID,Iversen Esben¹⁴,Kallemose Thomas¹,Juul‐Larsen Helle Gybel¹,Rasmussen Line Jee Hartmann¹⁵,Dalhoff Kim Peder³⁶,Andersen Ove¹³⁷,Eugen‐Olsen Jesper¹,Houlind Morten Baltzer¹²⁸^ORCID

Affiliation:

1. Department of Clinical Research Copenhagen University Hospital ‐ Amager and Hvidovre Copenhagen Denmark

2. The Capital Region Pharmacy Herlev Denmark

3. Department of Clinical Medicine University of Copenhagen Copenhagen Denmark

4. Icahn School of Medicine at Mount Sinai New York New York USA

5. Department of Psychology and Neuroscience Duke University Durham North Carolina USA

6. Department of Clinical Pharmacology Copenhagen University Hospital ‐ Bispebjerg and Frederiksberg Copenhagen Denmark

7. Emergency Department Copenhagen University Hospital ‐ Amager and Hvidovre Copenhagen Denmark

8. Department of Drug Design and Pharmacology University of Copenhagen Copenhagen Denmark

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14982

Reference66 articles.

1. Multimorbidity and mortality: A 15‐year longitudinal registry‐based nationwide Danish population study;Willadsen TG;J Comorbidity,2018

2. A Collaborative Medication Review Including Deprescribing for Older Patients in an Emergency Department: A Longitudinal Feasibility Study;Houlind MB;J Clin Med,2020

3. Prescribing for older adults;Boparai MK;Mt Sinai J Med N Y,2011

4. Prescribing for older people;Milton JC;BMJ,2008

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A characterization of patients with low soluble urokinase plasminogen activator receptor who died within 90 days of hospital discharge;Basic & Clinical Pharmacology & Toxicology;2024-07-11

2. Multimarkers approach in chest pain management in Emergency department: a focus on the prognostic role of sST2 and suPAR;Emergency Care Journal;2024-06-18

3. Role of soluble urokinase type plasminogen activator receptor (suPAR) in predicting mortality, readmission, length of stay and discharge in emergency patients: A systematic review and meta analysis;Medicine;2023-11-10

4. Soluble urokinase plasminogen activator receptor and decline in kidney function among patients without kidney disease;Clinical Kidney Journal;2022-02-21

5. Stratifying patients for polypharmacy interventions: The case for a new biomarker?;British Journal of Clinical Pharmacology;2021-10